{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:24:59Z","timestamp":1787030699289,"version":"build-2736575974"},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14520","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T03:58:39Z","timestamp":1719287919000},"source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of denosumab de\u2011escalation in giant cell tumor of bone"],"prefix":"10.3892","volume":"28","author":[{"given":"Eiji","family":"Nakata","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Hospital, Okayama 700\u20118558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kunisada","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Hospital, Okayama 700\u20118558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Hospital, Okayama 700\u20118558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyoshi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Hospital, Okayama 700\u20118558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Itano","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Hospital, Okayama 700\u20118558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Hospital, Okayama 700\u20118558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"key20240709110413_b1-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/CCO.0000000000000645","article-title":"Current concepts in the treatment of giant cell tumour of bone","volume":"32","author":"van der Heijden","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"key20240709110413_b2-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11912-021-01047-5","article-title":"Giant cell tumor of bone: An update","volume":"22","author":"Basu Mallick","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"key20240709110413_b3-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1097\/BRS.0b013e3182233ccd","article-title":"Giant cell tumor of the mobile spine: A review of 49 cases","volume":"37","author":"Boriani","year":"2012","journal-title":"Spine (Phila Pa 1976)"},{"key":"key20240709110413_b4-ol-28-2-14520","first-page":"443","article-title":"giant cell tumor of the sacrum: series of 19 patients and review of the literature","volume":"5","author":"Jamshidi","year":"2017","journal-title":"Arch Bone Jt Surg"},{"key":"key20240709110413_b5-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.3390\/cancers13153647","article-title":"Current concepts in the treatment of giant cell tumors of bone","volume":"13","author":"Tsukamoto","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20240709110413_b6-ol-28-2-14520","doi-asserted-by":"crossref","first-page":"1533033819840000","DOI":"10.1177\/1533033819840000","article-title":"Malignancy in giant cell tumor of bone: A review of the literature","volume":"1","author":"Palmerini","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"key20240709110413_b7-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/01.brs.0000261558.94247.8d","article-title":"Serial arterial embolization for large sacral giant-cell tumors: Mid- to long-term results","volume":"32","author":"Hosalkar","year":"2007","journal-title":"Spine (Phila Pa 1976)"},{"key":"key20240709110413_b8-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/os.12336","article-title":"Selective arterial embolization for the treatment of sacral and pelvic giant cell tumor: A systematic review","volume":"9","author":"He","year":"2017","journal-title":"Orthop Surg"},{"key":"key20240709110413_b9-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"580605","DOI":"10.3389\/fonc.2020.580605","article-title":"Denosumab in giant cell tumor of bone: Current status and pitfalls","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"key20240709110413_b10-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11864-020-00766-4","article-title":"Role of (Neo) adjuvant denosumab for giant cell tumor of bone","volume":"21","author":"Palmerini","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"key20240709110413_b11-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/curroncol28020124","article-title":"The role of denosumab for surgical outcomes in patients with giant cell tumour of bone: A systematic review","volume":"22","author":"Gupta","year":"2021","journal-title":"Curr Oncol"},{"key":"key20240709110413_b12-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00256-020-03449-1","article-title":"Radiological findings of denosumab treatment for giant cell tumours of bone","volume":"49","author":"van Langevelde","year":"2020","journal-title":"Skeletal Radiol"},{"key":"key20240709110413_b13-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(10)70170-4","article-title":"Denosumab in patients with giant-cell tumour of bone: An open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20240709110413_b14-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: Interim analysis of an open-label, parallel-group, phase 2 study","volume":"14","author":"Chawla","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20240709110413_b15-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S1470-2045(19)30663-1","article-title":"Denosumab in patients with giant-cell tumour of bone: A multicentre, open-label, phase 2 study","volume":"20","author":"Chawla","year":"2019","journal-title":"Lancet Oncol"},{"key":"key20240709110413_b16-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1245\/s10434-015-4634-9","article-title":"Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone","volume":"22","author":"Rutkowski","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"key20240709110413_b17-ol-28-2-14520","first-page":"e3792","article-title":"A: Malignant sarcomatous transformation of benign giant cell tumor of bone after treatment with denosumab therapy: A literature review of reported cases","volume":"28","author":"Alaqaili","year":"2018","journal-title":"Cureus"},{"key":"key20240709110413_b18-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejca.2017.01.028","article-title":"Denosumab in advanced\/unresectable giant-cell tumour of bone (GCTB): For how long?","volume":"76","author":"Palmerini","year":"2017","journal-title":"Eur J Cancer"},{"key":"key20240709110413_b19-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00256-015-2117-5","article-title":"Giant cell tumor: Rapid recurrence after cessation of long-term denosumab therapy","volume":"44","author":"Matcuk","year":"2015","journal-title":"Skeletal Radiol"},{"key":"key20240709110413_b20-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"100388","DOI":"10.1016\/j.jbo.2021.100388","article-title":"Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer","volume":"30","author":"Clemons","year":"2021","journal-title":"J Bone Oncol"},{"key":"key20240709110413_b21-ol-28-2-14520","first-page":"3809","article-title":"Efficacy and safety of de-escalation bone-modifying agents for cancer patients with bone metastases: A systematic review and meta-analysis. Cancer Manag","volume":"10","author":"Liu","year":"2018","journal-title":"Res"},{"key":"key20240709110413_b22-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"370","DOI":"10.25259\/SNI_439_2020","article-title":"Dosing interval adjustment of denosumab for the treatment of giant cell tumor of the sphenoid bone: A case report","volume":"11","author":"Tanikawa","year":"2020","journal-title":"Surg Neurol Int"},{"key":"key20240709110413_b23-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.2106\/JBJS.CC.16.00024","article-title":"Malignant transformation of a giant cell tumor of bone treated with denosumab: A case report","volume":"6","author":"Park","year":"2016","journal-title":"JBJS Case Connect"},{"key":"key20240709110413_b24-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.bjc.6605546","article-title":"Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer","volume":"102","author":"Hamaoka","year":"2010","journal-title":"Br J Cancer"},{"key":"key20240709110413_b25-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7150\/jca.1.80","article-title":"cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST","volume":"1","author":"Costelloe","year":"2010","journal-title":"J Cancer"},{"key":"key20240709110413_b26-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clbc.2012.09.004","article-title":"A prospective study of bone tumor response assessment in metastatic breast cancer","volume":"13","author":"Hayashi","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"key20240709110413_b27-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","article-title":"Giant-cell tumor of bone","volume":"69","author":"Campanacci","year":"1987","journal-title":"J Bone Joint Surg Am"},{"key":"key20240709110413_b28-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00002060-199110000-00007","article-title":"The interobserver reliability of the revised American Spinal Injury Association standards for neurological classification of spinal injury patients","volume":"70","author":"Priebe","year":"1991","journal-title":"Am J Phys Med Rehabil"},{"key":"key20240709110413_b29-ol-28-2-14520","article-title":"Reduced Dose-density of Denosumab for Unresectable GCTB (REDUCE)","volume-title":"ClinicalTrials.gov Identifier: NCT03620149","author":"European Organisation for Research and Treatment of Cancer","year":"2021"},{"key":"key20240709110413_b30-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijscr.2016.05.008","article-title":"Remarkable regression of a giant cell tumor of the cervical spine treated conservatively with denosumab: A case report","volume":"24","author":"Nakazawa","year":"2016","journal-title":"Int J Surg Case Rep"},{"key":"key20240709110413_b31-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"key20240709110413_b32-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jos.2019.05.003","article-title":"Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection?","volume":"25","author":"Sambri","year":"2020","journal-title":"J Orthop Sci"},{"key":"key20240709110413_b33-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/BRS.0000000000003728","article-title":"Denosumab treatment for giant cell tumor of the spine including the sacrum","volume":"46","author":"Bukata","year":"2021","journal-title":"Spine(Phila Pa 1976)"},{"key":"key20240709110413_b34-ol-28-2-14520","first-page":"767198","article-title":"Two cases of sarcoma arising in giant cell tumor of bone treated with denosumab. Case Rep","volume":"2015","author":"Broehm","year":"2015","journal-title":"Med"},{"key":"key20240709110413_b35-ol-28-2-14520","doi-asserted-by":"publisher","first-page":"e000663","DOI":"10.1136\/esmoopen-2019-000663","article-title":"Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: A case series analysis and literature review","volume":"5","author":"Raimondi","year":"2020","journal-title":"ESMO Open"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T11:46:22Z","timestamp":1732275982000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14520","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"article-number":"387"}}